Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,510 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Author Correction: Development of a sensitive, quantitative assay with broad subtype specificity for detection of total HIV-1 nucleic acids in plasma and PBMC.
Kibirige CN, Manak M, King D, Abel B, Hack H, Wooding D, Liu Y, Fernandez N, Dalel J, Kaye S, Imami N, Jagodzinski L, Gilmour J. Kibirige CN, et al. Among authors: king d. Sci Rep. 2022 Feb 1;12(1):1980. doi: 10.1038/s41598-022-06286-5. Sci Rep. 2022. PMID: 35105930 Free PMC article. No abstract available.
Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection.
Macharia GN, Yue L, Staller E, Dilernia D, Wilkins D, Song H, McGowan E, King D, Fast P, Imami N, Price MA, Sanders EJ, Hunter E, Gilmour J. Macharia GN, et al. Among authors: king d. PLoS Pathog. 2020 Sep 4;16(9):e1008853. doi: 10.1371/journal.ppat.1008853. eCollection 2020 Sep. PLoS Pathog. 2020. PMID: 32886726 Free PMC article.
A Novel Sample Selection Approach to Aid the Identification of Factors That Correlate With the Control of HIV-1 Infection.
Makinde J, Nduati EW, Freni-Sterrantino A, Streatfield C, Kibirige C, Dalel J, Black SL, Hayes P, Macharia G, Hare J, McGowan E, Abel B, King D, Joseph S; IAVI Protocol C Investigators; Hunter E, Sanders EJ, Price M, Gilmour J. Makinde J, et al. Among authors: king d. Front Immunol. 2021 Mar 11;12:634832. doi: 10.3389/fimmu.2021.634832. eCollection 2021. Front Immunol. 2021. PMID: 33777023 Free PMC article.
Breadth of CD8 T-cell mediated inhibition of replication of diverse HIV-1 transmitted-founder isolates correlates with the breadth of recognition within a comprehensive HIV-1 Gag, Nef, Env and Pol potential T-cell epitope (PTE) peptide set.
Hayes P, Fernandez N, Ochsenbauer C, Dalel J, Hare J, King D, Black L, Streatfield C, Kakarla V, Macharia G, Makinde J, Price M, Hunter E; IAVI protocol C investigators; Gilmour J. Hayes P, et al. Among authors: king d. PLoS One. 2021 Nov 17;16(11):e0260118. doi: 10.1371/journal.pone.0260118. eCollection 2021. PLoS One. 2021. PMID: 34788349 Free PMC article.
Author Correction: Development of a sensitive, quantitative assay with broad subtype specificity for detection of total HIV-1 nucleic acids in plasma and PBMC.
Kibirige CN, Manak M, King D, Abel B, Hack H, Wooding D, Liu Y, Fernandez N, Dalel J, Kaye S, Imami N, Jagodzinski L, Gilmour J. Kibirige CN, et al. Among authors: king d. Sci Rep. 2022 Jul 11;12(1):11792. doi: 10.1038/s41598-022-16308-x. Sci Rep. 2022. PMID: 35821052 Free PMC article. No abstract available.
Assessment of a diverse panel of transmitted/founder HIV-1 infectious molecular clones in a luciferase based CD8 T-cell mediated viral inhibition assay.
Fernandez N, Hayes P, Makinde J, Hare J, King D, Xu R, Rehawi O, Mezzell AT, Kato L, Mugaba S, Serwanga J, Chemweno J, Nduati E, Price MA, Osier F, Ochsenbauer C, Yue L, Hunter E, Gilmour J; IAVI protocol C investigators. Fernandez N, et al. Among authors: king d. Front Immunol. 2022 Dec 1;13:1029029. doi: 10.3389/fimmu.2022.1029029. eCollection 2022. Front Immunol. 2022. PMID: 36532063 Free PMC article.
4,510 results